Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. | Chief Operating Officer | Common Stock | 44.2K | $1.55M | $34.99 | May 23, 2024 | Direct |
Kymera Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 80.5K | Mar 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KYMR | Kymera Therapeutics, Inc. | May 23, 2024 | 1 | -$90.1K | 4 | May 23, 2024 | Chief Operating Officer |
KYMR | Kymera Therapeutics, Inc. | Mar 1, 2024 | 2 | $0 | 4 | Mar 4, 2024 | Chief Operating Officer |
KYMR | Kymera Therapeutics, Inc. | May 22, 2023 | 2 | $0 | 4 | May 22, 2023 | Chief Operating Officer |
KYMR | Kymera Therapeutics, Inc. | May 22, 2023 | 0 | $0 | 3 | May 22, 2023 | Chief Operating Officer |